The key finding
A 2025 review of complementary approaches for pediatric inflammatory bowel disease (IBD) found that mind-body practices—particularly cognitive behavioral therapy, yoga, and acupuncture—are associated with improved quality of life and may influence disease progression. Among gut microbiome interventions, probiotics and fecal microbiota transplant showed potential for disease modification, though safety data remain limited. Two plant compounds, curcumin and Indigo naturalis, demonstrated improvements in ulcerative colitis disease activity in clinical trials, but most studies focused on adults rather than children.
What the study looked like
This was a literature review examining complementary and alternative medicine (CAM) strategies that could be integrated alongside conventional medical treatments for pediatric IBD. The authors analyzed existing research across three broad categories: mind-body practices (including meditation, therapy, and acupuncture), microbiome-modulating interventions (probiotics, prebiotics, and fecal transplants), and herbal supplements with anti-inflammatory properties. The review specifically focused on therapies relevant to children and adolescents with Crohn’s disease or ulcerative colitis—the two main forms of IBD—though it acknowledged that much of the available evidence comes from adult populations. The authors evaluated both quality-of-life outcomes and potential disease-modifying effects across these interventions.
Why researchers think this happened
For mind-body practices, researchers propose that stress reduction and improved psychological well-being may influence inflammatory pathways, since stress is known to correlate with IBD flares. The gut-brain axis—the bidirectional communication between the digestive system and central nervous system—likely plays a role in how cognitive behavioral therapy and relaxation techniques affect disease activity. Regarding microbiome interventions, IBD involves dysbiosis (microbial imbalance), so reintroducing beneficial bacteria through probiotics or fecal transplant might restore healthier gut flora and reduce inflammation. Plant-based remedies like curcumin and Indigo naturalis contain compounds with documented anti-inflammatory properties in laboratory studies, which may explain their association with reduced ulcerative colitis symptoms. The authors noted these mechanisms align with prior research showing that IBD involves both immune dysregulation and altered gut bacterial communities.
How to read this carefully
This review synthesizes existing studies rather than presenting new clinical trial data, meaning conclusions depend on the quality of underlying research—which varies considerably. Many promising findings come from adult studies, so applicability to children remains uncertain. For microbiome interventions, the authors explicitly noted that more research evaluating safety and efficacy is needed, particularly since fecal transplants carry potential infection risks. The plant-based remedies showed improvements in disease activity scores, but “improvements” doesn’t mean cure, and Indigo naturalis has been associated with serious side effects in some cases. Sample sizes in many CAM studies are small, and few have been replicated in large pediatric populations. Importantly, this is observational and trial synthesis—not proof that these interventions will work for every child with IBD.
What this means for everyday life
If your child has IBD and you’ve wondered about approaches beyond medication, this review suggests certain complementary strategies may be worth discussing with their gastroenterologist. Mind-body practices like therapy and yoga appear relatively safe and are linked to better emotional well-being, which matters greatly during adolescence. Given the stress-gut connection, building these skills might support overall health even if disease modification remains uncertain. For microbiome strategies and herbal supplements, the evidence is more preliminary—these shouldn’t replace standard treatment, and any herbal product should be reviewed by your child’s medical team first, as some can interact with medications or cause unexpected side effects. The key takeaway is that “complementary” means alongside, not instead of, proven IBD therapies. Families seeking additional options now have a framework for conversations with providers about which approaches have emerging evidence and which need more pediatric research.